Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (ENGERIX-B) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
expired drug used; This non-serious case was reported by a consumer via sales rep and described the occurrence of expired vaccine used in a patient who received HBV (Engerix B pediatric) for prophylaxis. On an unknown date, the patient received Engerix B pediatric. On an unknown date, an unknown time after receiving Engerix B pediatric, the patient experienced expired vaccine used (Verbatim: expired drug used). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 08-APR-2025 The field representative reported a healthcare office inadvertently administered an expired pediatric dose of Engerix-B which led to expired vaccine used. GSK rep called this report in one callback placed to the reporting HCP but did not reach her.